Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
about
Etrolizumab for induction of remission in ulcerative colitisEtrolizumab for induction of remission in ulcerative colitisAnti-MAdCAM antibody for induction of remission in ulcerative colitisUse of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerElderly patients and inflammatory bowel diseaseUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Cancer and immunomodulators in inflammatory bowel diseases.Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.The role of vitamin D in gastrointestinal inflammation.The role and advances of immunomodulator therapy for inflammatory bowel disease.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.The epidemiology of inflammatory bowel disease.Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events.Inflammatory bowel disease and the elderly: a review.Monitoring for Extra-Intestinal Cancers in IBD.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Vedolizumab for the treatment of ulcerative colitis.The safety of non-biological treatments in Ulcerative Colitis.Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.Practical Approaches to "Top-Down" Therapies for Crohn's Disease.Management of Inflammatory Bowel Disease in the Elderly.Maintenance therapy options for ulcerative colitis.Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease.Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease.Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease.Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.Incidence, management, and course of cancer in patients with inflammatory bowel disease.Improving IBD Care: A Personalized Approach to Management.Vitamin D, the gut microbiome and inflammatory bowel disease
P2860
Q24186788-6B0271EE-D4AA-4E7C-9523-FC89ABE48B92Q24187269-1E0596A1-E6BC-4CCE-8987-01E6483E04D6Q24187593-CD69A1A9-89AC-4CAA-8190-C8A663EC01ACQ26750190-0159A030-9FA6-44E8-B92C-AE00FC603DF7Q26768270-18929AB2-A722-4444-A529-C512768FD860Q26996946-ED2C8F30-B609-4526-BA35-36E176873F5CQ33819478-8C3FAE19-B764-4449-99A7-A32E4541ABF0Q35534959-5518CBFC-C432-40D4-9E8B-691E6656C049Q36043446-7281FF31-27E8-4216-A031-275C39677A6FQ36378458-0CF50C39-C04F-4A92-9015-1FAA33A630DFQ38232289-9C5CE419-3F6E-4543-856A-01C39C11ABD1Q38237701-38D62BF1-30A4-4D16-B60C-AC64D0BC54E5Q38253832-4EE0C5BC-A752-407B-9A48-5BCED33A3EE4Q38357796-4EA50270-DE3A-4D6E-A8CF-2A3BCD59E7A3Q38394816-D5DB08A5-CF90-4F27-A79A-A9B6DA241512Q38419578-421A6050-DD91-48B1-B0CD-37DD20277634Q38585910-E5BEBF3B-A6E9-4B25-AD43-B3F4B4BD14D3Q38625992-80A2286F-FDDD-4A11-93C9-DF5D8064C9E1Q38633318-BD5349D1-9410-4F00-A636-349D6CFFD599Q38728164-D626B07C-D7A0-4F58-9299-31FB61046EABQ38830835-AD0B55B9-F0A0-4D2E-8CAB-F0E0BBF942FAQ38835478-F4059734-0182-4A1F-837B-CB3A80878A93Q38844393-349E0B65-60C2-4A2D-B7A0-976082A95ABCQ38848140-ED0499D6-B9F7-4E86-8598-699A7F9C753DQ38995675-9AD988EB-8829-461E-A2AD-3DA8BF443A91Q39043418-A020E65E-66FD-4C08-844E-635B1F356DF0Q39773210-73F33445-AC9F-4E62-9E40-2D5DC2E7C0D8Q40876895-40174F36-CDE9-4855-9258-9E2FAEFEB27EQ41139928-851AC8CC-72BA-438A-9985-F105AD4660E1Q42840586-EC14E2BA-A8D9-4AF6-BFE6-0B39CB66B063Q45943688-E1076378-9A51-44DC-8D84-4C8B1AC13699Q47555158-D823C24B-49EA-45EF-B373-E6DC19D4E049Q48180321-DE1BE06F-F665-43E4-87D2-0DEE94674719Q49616290-F0682766-406A-4DFD-B2D5-030B609C4E17Q50451653-EDF3B4F5-4E8A-483F-BD20-21B67F143BA0Q55512056-E125D355-92E7-44BD-AFD7-C2345E8036F9Q58712273-06C0A25F-8D38-40E3-AE5C-A60BFF0D3D67
P2860
Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Association between thiopurine ...... owel disease: a meta-analysis.
@en
Association between thiopurine ...... owel disease: a meta-analysis.
@en-gb
type
label
Association between thiopurine ...... owel disease: a meta-analysis.
@en
Association between thiopurine ...... owel disease: a meta-analysis.
@en-gb
prefLabel
Association between thiopurine ...... owel disease: a meta-analysis.
@en
Association between thiopurine ...... owel disease: a meta-analysis.
@en-gb
P356
P1476
Association between thiopurine ...... owel disease: a meta-analysis.
@en
P2093
Jonathan Ariyaratnam
P304
P356
10.1038/AJG.2013.451
P407
P577
2014-01-14T00:00:00Z